Education
About Us
Working with TipRanks
Follow Us
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989)
:9989
RESEARCH TOOLSreports
Comparison Results
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H
HK$5.93
HK$19.11B
19.95
85.31%
0 Buy
0 Hold
1 Sell
Moderate Sell
Shanghai Fosun Pharmaceutical (Group) Co
$2.85
$10.67B
16.80
85.06%
0 Buy
2 Hold
0 Sell
Hold
China Resources Pharmaceutical Group Ltd.
€0.52
€3.36B
9.23
-6.25%
0 Buy
0 Hold
0 Sell
Moderate Buy
CanSino Biologics, Inc. Class H
HK$51.90
HK$15.44B
―
179.33%
1 Buy
0 Hold
0 Sell
Moderate Buy
Performance Comparison
HK:9989
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H
5.93
2.77
87.66%
GB:HCM
HUTCHMED (China)
233.50
-27.50
-10.54%
SFOSF
Shanghai Fosun Pharmaceutical (Group) Co
2.85
1.29
82.69%
DE:640
China Resources Pharmaceutical Group Ltd.
0.52
-0.04
-7.14%
HK:1558
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H
14.38
6.48
82.03%
HK:6185
CanSino Biologics, Inc. Class H
51.90
33.10
176.06%